Media Releases and Task Force Announcements

Media Releases and Task Force Announcements2021-02-26T17:28:04-05:00

Extensive Study in Canada to Assess COVID-19 Vaccine Immune Responses and Effectiveness among People Living With HIV

People living with HIV are less likely to mount an adequate immune response, which may put them at higher risk for both serious COVID-19 illness and reduced response to COVID-19 vaccination. The Government of Canada, through its COVID-19 Immunity Task Force (CITF) and Vaccine Surveillance Reference Group (VSRG), is investing approximately $1.75 million in a study that will assess the immune responses, safety, and effectiveness of COVID-19 vaccination for this vulnerable population that has been understudied with respect to COVID-19.

New study to monitor COVID-19 illness and vaccine safety, effectiveness in children and youth in Canada

The CITF and VSRG are supporting a new pan-Canadian study that will monitor the effects of illness from COVID-19, as well as the safety and effectiveness of COVID-19 vaccines in children and youth. The study will be conducted through Canada’s IMPACT (Immunization Monitoring Program ACTive) network, which has been continuously monitoring multiple pediatric vaccines for more than 30 years.

June 11, 2021|Media Releases|

Recent blood donor data suggest that Canadians still remain vulnerable to SARS-CoV-2 infection

Blood donation organizations to provide important assessment of how long immunity lasts   NEWS RELEASE   MONTREAL, May 27, 2021 — Results from the latest Canadian Blood Services and Héma-Québec studies, which together cover all 10 provinces, confirm that from coast-to-coast, Canada’s overall levels of seroprevalence due to SARS-CoV-2 infection remained very low earlier this [...]

New Canada-Wide Research to Study Mixing-and-Matching COVID-19 vaccines

The Government of Canada, through the COVID-19 Immunity Task Force (CITF) and the Vaccine Surveillance Reference Group (VSRG), is supporting a new nation-wide study that will look at the effects of ‘mixing-and-matching’ approved COVID-19 vaccines in adults. Approximately $4.8 million is being provided for this study, which will assess the safety and effectiveness of using two different COVID-19 vaccines for the first and second dose. The project will also study the effects of increasing the interval between doses.

Preliminary results suggest nearly 6% of Montreal children tested from October to April had antibodies to SARS-CoV-2

Preliminary results from a study underway in Montreal shed important light on the extent to which 2 to 17 years-old have had COVID-19 between last October 2020 and this April 2021. As an overall average, 5.8% of participating children were found to have antibodies to SARS-CoV-2, the virus that causes COVID-19.

May 18, 2021|Media Releases, Pediatrics|

Studies being launched to support vaccine effectiveness and safety monitoring across Canada

A consortium of Canadian organizations, including the Public Health Agency of Canada (PHAC), the Canadian Research Immunization Network (CIRN), the National Advisory Committee on Immunization (NACI) and the CITF, are collaborating through the Vaccine Surveillance Reference group (VSRG) to identify new studies to support comprehensive vaccine effectiveness and safety monitoring efforts across Canada.

How well does vaccination work in residents of long-term care homes? Researchers aim to find out.

Long-term care homes have been at the epicentre of the COVID-19 pandemic in Canada, with 70 percent of COVID-19 deaths having occurred in long-term care or nursing homes. The Government of Canada, through the CITF, is supporting a study led by McMaster University researchers aimed at understanding how well vaccination works in residents of long-term care homes and which factors may be directly linked to outbreaks.

March 18, 2021|Media Releases|

Researchers investigate COVID-19 among high-risk food workers in Quebec and Ontario

Throughout this pandemic, thousands of Canadians have had to continue working to provide essential services, such as in food production and packing plants, as well as in grocery stores, restaurants, and bars. At times, this has meant working in close proximity to colleagues and customers. The Government of Canada, through its COVID-19 Immunity Task Force (CITF), is providing approximately $4.5 million to support two studies looking at the impact of various aspects of COVID-19 on food industry workers in Quebec and Ontario.

March 17, 2021|Media Releases|

New study in Quebec long-term care facilities to investigate the science behind why so many residents had severe cases of COVID-19

Across Canada, but particularly in Quebec, long-term care facilities have accounted for a disproportionate number of COVID-19 deaths. The Government of Canada, through the CITF, is supporting a new $2.7 million study aimed at identifying the factors putting each person at risk of developing severe COVID-19 symptoms and medical complications that may lead to a fatal disease.

March 11, 2021|Media Releases|
Go to Top